Stoke Therapeutics (STOK) Net Margin Growth (1y) (2023 - 2026)
Powered by 
Analysis
Stoke Therapeutics (STOK) Net Margin Growth (1y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -185.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -763.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 529.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 4,168.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 673.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2,208.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -392.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,636.00 |
| 10 | Stoke Therapeutics | 1.96 Bn | 1.67 Bn | - | -49,083.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -49,083.00 |
| Mar 31, 2026 | -87,393.00 |
| Dec 31, 2025 | -407,715.00 |
| Sep 30, 2025 | 17,937.00 |
| Jun 30, 2025 | 36,192.00 |
| Mar 31, 2025 | 69,676.00 |
| Dec 31, 2024 | 91,632.00 |
| Sep 30, 2024 | 20,309.00 |
| Jun 30, 2024 | 79,996.00 |
| Mar 31, 2024 | -15,754.00 |
| Dec 31, 2023 | -17,724.00 |
| Sep 30, 2023 | 15,714.00 |
| Jun 30, 2023 | -53,240.00 |
| Mar 31, 2023 | 37,567.00 |